Cornercap Investment Counsel Inc Enanta Pharmaceuticals Inc Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 13,785 shares of ENTA stock, worth $181,134. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,785
Previous 13,536
1.84%
Holding current value
$181,134
Previous $127,000
88.98%
% of portfolio
0.04%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
21.7MCall Options Held
9.4KPut Options Held
3.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$27.5 Million0.17% of portfolio
-
Morgan Stanley New York, NY2.05MShares$26.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$25.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.84MShares$24.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.24MShares$16.2 Million0.29% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $272M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...